SCHOTT Pharma AG & Co. KGaA
1SXP DE000A3ENQ51
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a subsidiary of the glass manufacturer Otto Schott, the company went private and subsequently entered the Frankfurst Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries.
Annual Performance 1
2023 | 2024 | 2025 |
---|---|---|
7% | -24% | 3% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Schulte, Dr. Jens DIR |
40.00 EUR |
2,000 Sold |
80,000 EUR |
05/03/2024 | 01/03/2024 |
Goldschmidt, Peter DIR |
27.00 EUR |
1,852 Bought |
50,004 EUR |
06/10/2023 | 02/10/2023 |
Erkens, Ann-kristin DIR |
27.00 EUR |
1,755 Bought |
47,385 EUR |
06/10/2023 | 02/10/2023 |
Reisse, Andreas DIR |
27.00 EUR |
3,509 Bought |
94,743 EUR |
06/10/2023 | 02/10/2023 |
Schulte, Dr. Jens DIR |
27.00 EUR |
3,509 Bought |
94,743 EUR |
06/10/2023 | 02/10/2023 |
Wienand, Dr. Wolfgang DIR |
27.00 EUR |
1,754 Bought |
47,358 EUR |
06/10/2023 | 02/10/2023 |
Steinkühler, Dr. Almuth DIR |
27.00 EUR |
1,852 Bought |
50,004 EUR |
06/10/2023 | 02/10/2023 |